304 related articles for article (PubMed ID: 27071792)
1. Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD).
Liu H; Talalay P; Fahey JW
CNS Neurol Disord Drug Targets; 2016; 15(5):602-13. PubMed ID: 27071792
[TBL] [Abstract][Full Text] [Related]
2. Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder.
Liu H; Zimmerman AW; Singh K; Connors SL; Diggins E; Stephenson KK; Dinkova-Kostova AT; Fahey JW
Sci Rep; 2020 Apr; 10(1):5822. PubMed ID: 32242086
[TBL] [Abstract][Full Text] [Related]
3. Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets.
Baranova J; Dragunas G; Botellho MCS; Ayub ALP; Bueno-Alves R; Alencar RR; Papaiz DD; Sogayar MC; Ulrich H; Correa RG
Cell Mol Neurobiol; 2021 May; 41(4):619-649. PubMed ID: 32468442
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis.
Frye RE; Rincon N; McCarty PJ; Brister D; Scheck AC; Rossignol DA
Neurobiol Dis; 2024 Jul; 197():106520. PubMed ID: 38703861
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane Treatment of Young Men with Autism Spectrum Disorder.
Singh K; Zimmerman AW
CNS Neurol Disord Drug Targets; 2016; 15(5):597-601. PubMed ID: 27071786
[TBL] [Abstract][Full Text] [Related]
6. Targeted Biomedical Treatment for Autism Spectrum Disorders.
Pacheva I; Ivanov I
Curr Pharm Des; 2019; 25(41):4430-4453. PubMed ID: 31801452
[TBL] [Abstract][Full Text] [Related]
7. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.
Khemakhem AM; Frye RE; El-Ansary A; Al-Ayadhi L; Bacha AB
Metab Brain Dis; 2017 Dec; 32(6):1983-1997. PubMed ID: 28831647
[TBL] [Abstract][Full Text] [Related]
8. Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions.
Lacivita E; Perrone R; Margari L; Leopoldo M
J Med Chem; 2017 Nov; 60(22):9114-9141. PubMed ID: 29039668
[TBL] [Abstract][Full Text] [Related]
9. Hormesis, cellular stress response, and redox homeostasis in autism spectrum disorders.
Calabrese V; Giordano J; Ruggieri M; Berritta D; Trovato A; Ontario ML; Bianchini R; Calabrese EJ
J Neurosci Res; 2016 Dec; 94(12):1488-1498. PubMed ID: 27642708
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
Rose S; Niyazov DM; Rossignol DA; Goldenthal M; Kahler SG; Frye RE
Mol Diagn Ther; 2018 Oct; 22(5):571-593. PubMed ID: 30039193
[TBL] [Abstract][Full Text] [Related]
11. The Role of Vitamins in Autism Spectrum Disorder: What Do We Know?
Bjørklund G; Waly MI; Al-Farsi Y; Saad K; Dadar M; Rahman MM; Elhoufey A; Chirumbolo S; Jóźwik-Pruska J; Kałużna-Czaplińska J
J Mol Neurosci; 2019 Mar; 67(3):373-387. PubMed ID: 30607900
[TBL] [Abstract][Full Text] [Related]
12. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.
Bhandari R; Paliwal JK; Kuhad A
Adv Neurobiol; 2020; 24():615-646. PubMed ID: 32006377
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.
Bjørklund G; Meguid NA; El-Ansary A; El-Bana MA; Dadar M; Aaseth J; Hemimi M; Osredkar J; Chirumbolo S
J Mol Neurosci; 2018 Dec; 66(4):492-511. PubMed ID: 30357679
[TBL] [Abstract][Full Text] [Related]
14. An Open-Label Case Series of Glutathione Use for Symptomatic Management in Children with Autism Spectrum Disorder.
Radwan K; Wu G; Banks-Word K; Rosenberger R
Med Sci (Basel); 2023 Nov; 11(4):. PubMed ID: 37987328
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder.
El-Ansary A; Bjørklund G; Chirumbolo S; Alnakhli OM
Metab Brain Dis; 2017 Aug; 32(4):1209-1221. PubMed ID: 28497358
[TBL] [Abstract][Full Text] [Related]
16. Autism spectrum disorder (ASD) - biomarkers of oxidative stress and methylation and transsulfuration cycle.
Waligóra A; Waligóra S; Kozarska M; Damasiewicz-Bodzek A; Gorczyca P; Tyrpień-Golder K
Psychiatr Pol; 2019 Aug; 53(4):771-788. PubMed ID: 31760409
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder.
Frye RE; Rossignol DA; Scahill L; McDougle CJ; Huberman H; Quadros EV
Semin Pediatr Neurol; 2020 Oct; 35():100835. PubMed ID: 32892962
[TBL] [Abstract][Full Text] [Related]
18. Antineuroinflammatory therapy: potential treatment for autism spectrum disorder by inhibiting glial activation and restoring synaptic function.
Li YJ; Zhang X; Li YM
CNS Spectr; 2020 Aug; 25(4):493-501. PubMed ID: 31659946
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder.
Barone R; Rizzo R; Tabbì G; Malaguarnera M; Frye RE; Bastin J
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995737
[TBL] [Abstract][Full Text] [Related]
20. Autism spectrum disorder (ASD): Disturbance of the melatonin system and its implications.
Wu ZY; Huang SD; Zou JJ; Wang QX; Naveed M; Bao HN; Wang W; Fukunaga K; Han F
Biomed Pharmacother; 2020 Oct; 130():110496. PubMed ID: 32682113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
